BLAZE-Limiting Approach in NMOSD
Completed
- Conditions
- Neuromyelitis Optica Spectrum Disorders (NMOSD)
- Interventions
- First Posted Date
- 2025-03-21
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 9
- Registration Number
- NCT06888622
- Locations
- 🇨🇳
Huashan Hospital, Shanghai, Shanghai, China
HANDLE-a Real World Study on Satralizumab in NMOSD
Not yet recruiting
- Conditions
- Neuromyelitis Optica Spectrum Disorders (NMOSD)
- Interventions
- First Posted Date
- 2025-02-17
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06829524
- Locations
- 🇨🇳
Huashan Hospital, Shanghai, Shanghai, China
Establishment of the Chinese Preclinical Alzheimer's Disease Study With Multiple Neuroimaging
Recruiting
- Conditions
- Alzheimer DiseasePositron Emission Tomography
- First Posted Date
- 2025-02-14
- Last Posted Date
- 2025-06-05
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 3000
- Registration Number
- NCT06827678
- Locations
- 🇨🇳
Huashan Hospital, Shanghai, China
OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study)
Phase 3
Recruiting
- Conditions
- Primary Membranous Nephropathy
- Interventions
- Drug: Glucocorticoids
- First Posted Date
- 2025-01-17
- Last Posted Date
- 2025-01-17
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 144
- Registration Number
- NCT06781944
- Locations
- 🇨🇳
Huashan Hospital, Fudan University, Shanghai, Shanghai, China
Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery
Phase 2
Not yet recruiting
- Conditions
- Glioblastoma
- Interventions
- Drug: Vebreltinib + Temozolomide
- First Posted Date
- 2025-01-17
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT06780592
The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors
Phase 2
Recruiting
- Conditions
- Gastrointestinal Tumors
- Interventions
- Drug: propranolol (beta-blocker used treat high blood pressure)
- First Posted Date
- 2025-01-14
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT06775080
- Locations
- 🇨🇳
Huashan Hospital, Fudan University, Shanghai, Shanghai, China
Incremental Dialysis Decision Model Based on Expert-Guided Machine Learning
Completed
- Conditions
- End-stage Renal Disease
- First Posted Date
- 2025-01-14
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 175
- Registration Number
- NCT06775067
- Locations
- 🇨🇳
Huashan hospital, Fudan university, Shanghai, Shanghai, China
Rapid Kidney Function Decline in Older Adults
Completed
- Conditions
- Kidney Function DeclineGlomerular Filtration RateUrine Albumin-creatinine RatioHealthy AgingComorbidityChronic Kidney Disease
- First Posted Date
- 2025-01-09
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 1539
- Registration Number
- NCT06765811
- Locations
- 🇨🇳
Huashan hospital, Fudan university, Shanghai, Shanghai, China
PDO Based Drug Sensitive Test in R/M SGC
Active, not recruiting
- Conditions
- Salivary Gland CancersPatient Derived OrganoidDrug Sensitive Test in Vitro
- First Posted Date
- 2024-11-13
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT06686979
- Locations
- 🇨🇳
Huashan Hospital, Fudan University, Shanghai, Shanghai, China
PDO Based Drug Sensitive Test in R/M HNSCC
Active, not recruiting
- Conditions
- Head and Neck Squamous Cell CarcinomaPatient Derived OrganoidDrug Sensitive Test in Vitro
- First Posted Date
- 2024-11-13
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06686342
- Locations
- 🇨🇳
Huashan Hospital, Fudan University, Shanghai, Shanghai, China